Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31:1770–86. https://doi.org/10.1038/s41379-018-0110-y.

Article  PubMed  PubMed Central  Google Scholar 

WHO Classification of Tumours Editorial Board. Thoracic tumours. 3rd ed. Lyon, France: International Agency for Research on Cancer; 2021.

Google Scholar 

Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer. 2019;19(5):289–97. https://doi.org/10.1038/s41568-019-0133-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

George J, Lim JS, Jang SJ, Cun Y, Ozretić L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524(7563):47–53. https://doi.org/10.1038/nature14664. (Epub 2015 Jul 13).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rekhtman N, Pietanza MC, Hellmann MD, Naidoo J, Arora A, Won H, et al. Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets. Clin Cancer Res. 2016;22:3618–29. https://doi.org/10.1158/1078-0432.CCR-15-2946.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Papaxoinis G, Lamarca A, Quinn AM, Mansoor W, Nonaka D. Clinical and pathologic characteristics of pulmonary carcinoid tumors in central and peripheral locations. Endocr Pathol. 2018;29:259–68. https://doi.org/10.1007/s12022-018-9530-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alcala N, Leblay N, Gabriel AAG, Mangiante L, Hervas D, Giffon T, et al. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Nat Commun. 2019;10:3407. https://doi.org/10.1038/s41467-019-11276-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laddha SV, da Silva EM, Robzyk K, Untch BR, Ke H, Rekhtman N, et al. Integrative genomic characterization identifies molecular subtypes of lung carcinoids. Cancer Res. 2019;79:4339–47. https://doi.org/10.1158/0008-5472.CAN-19-0214.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y, et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol. 2006;24:70–6. https://doi.org/10.1200/JCO.2005.04.1202.

Article  PubMed  Google Scholar 

Ferolla P, Daddi N, Urbani M, Semeraro A, Ribacchi R, Giovenali P, et al. Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids. J Thorac Oncol. 2009;4:383–7. https://doi.org/10.1097/JTO.0b013e318197f2e7.

Article  PubMed  Google Scholar 

Wang Y, Chen Y, Yang Z, Qian F, Hu M, Lu J, et al. Different characteristics and survival between surgically resected pure and combined pulmonary large cell neuroendocrine carcinoma. Ann Surg Oncol. 2022;29:5666–78. https://doi.org/10.1245/s10434-022-11610-4. (Epub 2022 May 11).

Article  PubMed  Google Scholar 

Skuladottir H, Hirsch FR, Hansen HH, Olsen JH. Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer. 2002;37:127–35. https://doi.org/10.1016/s0169-5002(02)00080-6.

Article  PubMed  Google Scholar 

National Comprehensive Cancer Network Guidelines (2024). https://www.nccn.org/guidelines/recently-published-guidelines.

Fox M, Van Berkel V, Bousamra M 2nd, Sloan S, Martin RC 2nd. Surgical management of pulmonary carcinoid tumors: sublobar resection versus lobectomy. Am J Surg. 2013;205(2):200–8. https://doi.org/10.1016/j.amjsurg.2012.05.008.

Article  PubMed  Google Scholar 

Namikawa S, Den T, Kimura M, Kusagawa M. The role of surgical resection and the effects of neo-adjuvant therapy in the management of small cell lung cancer. Surg Today. 1994;24:342–6. https://doi.org/10.1007/BF02348565.

Article  CAS  PubMed  Google Scholar 

Niiranen A. Long-term survival in small cell carcinoma of the lung. Eur J Cancer Clin Oncol. 1988;24:749–52. https://doi.org/10.1016/0277-5379(88)90310-0.

Article  CAS  PubMed  Google Scholar 

Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwards JG, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2024. https://doi.org/10.1016/j.jtho.2024.02.011. (Epub ahead of print).

Article  PubMed  Google Scholar 

La Rosa S, Uccella S. Classification of neuroendocrine neoplasms: lights and shadows. Rev Endocr Metab Disord. 2021;22:527–38. https://doi.org/10.1007/s11154-020-09612-2. (Epub 2020 Nov 9).

Article  PubMed  Google Scholar 

Uccella S, La Rosa S, Volante M, Papotti M. Immunohistochemical biomarkers of gastrointestinal, pancreatic, pulmonary, and thymic neuroendocrine neoplasms. Endocr Pathol. 2018;29:150–68. https://doi.org/10.1007/s12022-018-9522-y.

Article  PubMed  Google Scholar 

Derks JL, Leblay N, Lantuejoul S, Dingemans AC, Speel EM, Fernandez-Cuesta L. New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management. J Thorac Oncol. 2018;13:752–66. https://doi.org/10.1016/j.jtho.2018.02.002. Epub 2018 Feb 14. Erratum in: J Thorac Oncol. 2018 Aug;13(8):1229.

Song P, Zang R, Liu L, Dan X, Gao S. Long-term outcomes and prognostic factors of patients with surgically treated pulmonary atypical carcinoid tumors: our institutional experience with 68 patients. J Thorac Dis. 2018;10:4204–11. https://doi.org/10.21037/jtd.2018.06.88.

Article  PubMed  PubMed Central  Google Scholar 

Lee PC, Osakwe NC, Narula N, Port JL, Paul S, Stiles BM, et al. Predictors of disease-free survival and recurrence in patients with resected bronchial carcinoid tumors. Thorac Cardiovasc Surg. 2016;64(2):159–65. https://doi.org/10.1055/s-0035-1544211.

Article  PubMed  Google Scholar 

Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, et al. Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376:125–35. https://doi.org/10.1056/NEJMoa1607427.

Article  CAS  PubMed  PubMed Central  Google Scholar